InsidersTradesSigma
Follow the GC메디아이 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, GC메디아이 has recorded 5 reports. Market capitalisation: €146bn. The latest transaction was disclosed on 8 May 2026 (Other). Among the most active insiders: GC케어. Every trade is openly available.
4
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
n/a
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 1,165 of 29,064 companies
80.2
score / 100
Value84
Quality76
FCF yld3.5%
Earn yld23%
EV/EBITDA3.9x
ROE·
Gross mgn52%
Net mgn19%
Debt/EBITDA0.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 8 May 2026
Acerca de GC메디아이
GC메디아이 es una empresa que opera en el sector de la salud y farmacéutico, cotizando en el mercado XKRX. Se enfoca en el desarrollo de soluciones médicas innovadoras.